» Articles » PMID: 1832057

Synergistic Interactions Between Interleukin-11 and Interleukin-4 in Support of Proliferation of Primitive Hematopoietic Progenitors of Mice

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1991 Sep 15
PMID 1832057
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-11 (IL-11) is a newly identified lymphohematopoietic cytokine originally derived from the primate bone marrow stromal cell line, PU-34. Separately, we reported that IL-11 augments IL-3-dependent proliferation of primitive murine hematopoietic progenitors in culture. We have now examined the synergistic interactions between IL-11 and IL-4 in support of colony formation from marrow cells of mice treated 2 days before with 150 mg/kg 5-fluorouracil. Neither recombinant human IL-11 nor murine IL-4 alone was effective in the support of colony formation. When the two factors were combined, there was major enhancement of colony formation, including that of multilineage colony-forming cells. Serial observations (mapping studies) of development of multipotential blast cell colonies indicated that the synergy between IL-11 and IL-4 is due in part to shortening of the dormant period of the stem cells, an effect very similar to that of IL-6 and granulocyte colony-stimulating factor. The combination of IL-11 and IL-4 may be useful in the stimulation of dormant hematopoietic stem cells in vivo.

Citing Articles

Targeting IL-6 trans-signalling: past, present and future prospects.

Rose-John S, Jenkins B, Garbers C, Moll J, Scheller J Nat Rev Immunol. 2023; 23(10):666-681.

PMID: 37069261 PMC: 10108826. DOI: 10.1038/s41577-023-00856-y.


Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.

Metcalfe R, Putoczki T, Griffin M Front Immunol. 2020; 11:1424.

PMID: 32765502 PMC: 7378365. DOI: 10.3389/fimmu.2020.01424.


A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia.

Usuki K, Urabe A, Ikeda Y, Ohashi Y, Mizoguchi H, Takaku F Int J Hematol. 2007; 85(1):59-69.

PMID: 17261503 DOI: 10.1532/IJH97.06027.


Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3).

Magrangeas F, Boisteau O, Denis S, Jacques Y, Minvielle S Biochem J. 2001; 353(Pt 2):223-30.

PMID: 11139384 PMC: 1221562. DOI: 10.1042/0264-6021:3530223.


Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Hawley R, Hawley T, Fong A, Quinto C, Collins M, Leonard J Proc Natl Acad Sci U S A. 1996; 93(19):10297-302.

PMID: 8816794 PMC: 38378. DOI: 10.1073/pnas.93.19.10297.